NDC 86012-3003 - Integrity Pre-Post Part A
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86012-3003
- Package NDCs from labels
- 86012-3003-1, 86012-3003-2, 86012-3003-3, 86012-3003-4
- Manufacturer
- Premier Select Sires
- Effective date
- 2022-11-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Integrity Pre-Post Part A - Premier Select Sires | Premier Select Sires | 2022-11-21 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86012-3003-1 | Integrity Pre-Post Part A | 19 kg in 1 CONTAINER | SOLUTION | 19 | 1 | |
| 86012-3003-2 | Integrity Pre-Post Part A | 57 kg in 1 DRUM | SOLUTION | 57 | 1 | |
| 86012-3003-3 | Integrity Pre-Post Part A | 208 kg in 1 DRUM | SOLUTION | 208 | 1 | |
| 86012-3003-4 | Integrity Pre-Post Part A | 1041 kg in 1 CONTAINER | SOLUTION | 1041 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 86012-3003 | INTEGRITY PRE-POST PART A (LACTIC ACID) SOLUTION [PREMIER SELECT SIRES] | 1 | 4 package rows | 20221123_ea163dff-3aed-4c51-a032-855bc49ca293.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glucose Control T015 | SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM | Guangzhou Renuma Medical Systems Co., Ltd | 3fd02c0a-5cf1-4f35-86d0-d5d09e63f39b | 2017-10-26 | Warnings | 33X04XA5AT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.